MTOR and acute graft versus host disease: Thus, activated CD3+CD8+ T cells showed no major differences in IL-6 responsiveness when comparing patients with and without previous acute GVHD; this is in contrast to the CD3+CD4+ T cell subset that differed in STAT (Ser727) and mTOR (Ser2448) responses between the two patient subsets.